Company intelligence / Profile preview

Maela

Champagne au Mont d'Or, Rhône-Alpes, Francemaela.fr ↗

Ownership: Private
Development stage: Other

Overview

Maela developed and commercialized a digital health platform enabling healthcare professionals to remotely monitor patients, particularly those undergoing surgery. The solution supported preparation, follow-up, and personalized care pathways. The company was active until its merger with Nouveal e-Sante in January 2023.

Therapeutic areas: Other
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Nouveal e-SanteSword Group

Beyond the preview

Go deeper on Maela.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maela.

Explore the full profile